EUVIMEDEUVIMED entdecken
Crossref

Evaluation of serial monitoring of donor‐specific antibodies in pediatric and adult intestinal/multivisceral transplant recipients

Kelsey Klein iD, Megan Keck, Eric Langewisch, Shaheed Merani iD, Kelley Hitchman iD, Mary Leick

Pediatric Transplantation · 2024

DOI: 10.1111/petr.14638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Kelsey Klein und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Health Transplant Institute, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Transplant Recipients, Kidney Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The study purpose was to add to limited literature assessing anti‐HLA donor‐specific antibody (DSA) appearance, clearance, specificity, and impact in intestinal/multivisceral (MV) transplant as well as the value of serial monitoring following an institutional protocol shift implementing serial monitoring.

Methods

This single‐center retrospective review included intestinal/MV recipients transplanted 1/1/15–9/31/17 with completed DSA testing. Patients were divided into groups based on DSA presence post‐transplant. The primary outcome was biopsy‐proven acute rejection (BPAR). Secondary outcomes included graft loss and death. Descriptive analysis of DSA was completed.

Results

Of the 35 intestinal/MV recipients (60% pediatric) with DSA testing, 24 patients had post‐transplant DSA. Fifteen patients in the DSA(+) group had T‐cell‐mediated BPAR versus five in the DSA(−) group (63% vs 45%, p = .47). Days to BPAR were 25 [IQR 19–165] (DSA(+) group) versus 232 [IQR 25.5–632.5] (DSA(−) group) ( p = .066). There were no differences between groups for graft loss or death. One hundred and five DSA were identified in the DSA(+) group with 63% being class II, and 54% cleared during follow‐up. DSA were directed against 50 different HLA alleles, with the most common being directed against HLA‐ DQ (35%). Time to first DSA and to clearance did not differ between class I and II.

Conclusion

Findings confirm previous data that suggest post‐transplant DSA in this population may lead to increased BPAR or shorter time to BPAR, although not statistically significant. Most DSA were identified within the first month after transplant, and ahead of rejection identification on biopsy. DSA therefore may have utility as an early rejection biomarker and use may be considered in place of early protocol biopsies, particularly in pediatric patients. We identified novel findings of DSA directed against a large breadth of HLA in intestinal/MV patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplant RecipientsKidney TransplantationAdultHumansChildHLA AntigensAntibodiesTissue DonorsRetrospective StudiesAntilymphocyte SerumGraft RejectionGraft SurvivalIsoantibodies

Stichwörter der Autor:innen

antibody-mediated rejectiondonor-specific antibodiesintestinal (allograft) function/dysfunctionintestinal transplantationmonitoring: Immunemultivisceral transplantation

Substanzen

HLA AntigensAntibodiesAntilymphocyte SerumIsoantibodies

Autor:innen und Institutionen

  • University Health Transplant Institute, San Antonio, Texas, USA.
  • The University of Texas at Austin, College of Pharmacy, Pharmacotherapy Division, Austin TX, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
  • Nebraska Medicine, Omaha, NE, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Pathology and Laboratory Medicine, UT Health San Antonio, San Antonio, Texas, USA.

ORCID-Profile: Kelsey Klein, Shaheed Merani, Kelley Hitchman

Zitieren

APA

Klein, K., Keck, M., Langewisch, E., Merani, S., Hitchman, K., & Leick, M. (2024). Evaluation of serial monitoring of donor‐specific antibodies in pediatric and adult intestinal/multivisceral transplant recipients. Pediatric Transplantation. https://doi.org/10.1111/petr.14638

Vancouver

Klein K, Keck M, Langewisch E, Merani S, Hitchman K, Leick M. Evaluation of serial monitoring of donor‐specific antibodies in pediatric and adult intestinal/multivisceral transplant recipients. Pediatric Transplantation. 2024. doi:10.1111/petr.14638

BibTeX
@article{Klein2024,
  author = {Klein, Kelsey and Keck, Megan and Langewisch, Eric and Merani, Shaheed and Hitchman, Kelley and Leick, Mary},
  title = {Evaluation of serial monitoring of donor‐specific antibodies in pediatric and adult intestinal/multivisceral transplant recipients},
  journal = {Pediatric Transplantation},
  year = {2024},
  doi = {10.1111/petr.14638}
}
Kostenlos starten →